Bolt Biotherapeutics, Inc. · NASDAQ:BOLT
Nan Fung Group Holdings Ltd reported a 6.70% stake in Bolt Biotherapeutics, Inc. (Schedule 13D/A)
Event Feb 5, 2026 · Filed Feb 17, 2026
Nan Fung Group Holdings Ltd reported a 6.70% stake in Bolt Biotherapeutics, Inc., 128,119 shares, with active intent on Feb 5, 2026. Filed Feb 17, 2026 (Schedule 13D/A).
- Stake
- 6.70%
- Shares
- 128,119
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 11 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Nan Fung Group Holdings Limited | 6.70% | 128,119 |
| NF Investment Holdings Limited | 6.70% | 128,119 |
| Pivotal bioVenture Partners Fund I, L.P. | 4.10% | 78,445 |
| Pivotal bioVenture Partners Fund I G.P., L.P. | 4.10% | 78,445 |
| Pivotal bioVenture Partners Fund I U.G.P. Ltd. | 4.10% | 78,445 |
| Pivotal Partners Ltd | 4.10% | 78,445 |
| Pivotal Life Sciences Holdings Limited | 4.10% | 78,445 |
| Nan Fung Life Sciences Holdings Limited | 6.40% | 123,119 |
| Permwell Management Limited | 0.30% | 5,000 |
| NFLS Beta Limited | 2.30% | 44,674 |
| NFLS Platform Holdings Limited | 2.30% | 44,674 |
Source
Related
- Bolt Biotherapeutics, Inc.
- Nan Fung Group Holdings Ltd
- Bolt Biotherapeutics, Inc. shareholders
- Schedule 13D/A · Nan Fung Group Holdings Ltd · Feb 26, 2026
- Form 4 · Yonehiro Grant · Sep 21, 2026
- Form 4 · Nemec Sarah · Sep 21, 2026
- Form 4 · Quinn William P. · Sep 21, 2026
- Schedule 13G · Renaissance Technologies LLC · Aug 13, 2026
- Schedule 13G/A · Vivo Panda Fund, L.P. · Feb 13, 2026